Literature DB >> 19561447

IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease.

Siu-Ki Chan1, Wah Cheuk, Kwan-Tsz Chan, John K C Chan.   

Abstract

IgG4-related sclerosing disease is a distinctive mass-forming lesion with frequent systemic involvement, most frequently the pancreas, salivary glands, and lacrimal glands. This report describes a case manifesting with a previously unrecognized form of central nervous system involvement. The 37-year-old man presented with signs and symptoms of spinal cord compression at the thoracic level 9. Magnetic resonance imaging revealed an elongated dural mass extending from the fifth to tenth thoracic vertebra. Laminectomy and excision of the mass revealed dura expanded by a dense lymphoplasmacytic infiltrate accompanied by stromal fibrosis and phlebitis. IgG4+ plasma cells were increased and the proportion of IgG4+/IgG+ plasma cells was 85%. The patient also had a 1-year history of bilateral submandibular swelling due to chronic sialadenitis. Thus, IgG4-related sclerosing pachymeningitis represents a new member of the IgG4-related sclerosing disease family affecting the central nervous system. It seems that at least a proportion of cases described in the literature as idiopathic hypertrophic pachymeningitis belong to this disease, especially as some patients have other clinical manifestations compatible with IgG4-related sclerosing disease, such as cholangitis and orbital pseudotumor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561447     DOI: 10.1097/PAS.0b013e3181abdfc2

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  46 in total

1.  Radiological features of IgG4-related disease in the head, neck, and brain.

Authors:  Masaki Katsura; Harushi Mori; Akira Kunimatsu; Hiroki Sasaki; Osamu Abe; Toru Machida; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2012-02-23       Impact factor: 2.804

Review 2.  The Clinical and Pathological Features of IgG(4)-Related Disease.

Authors:  Arezou Khosroshahi; Vikram Deshpande; John H Stone
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

Review 3.  Cervicothoracic spinal cord compression caused by IgG4-related sclerosing pachymeningitis: a case report and literature review.

Authors:  Rui Gu; Peng-Yuan Hao; Jia-Bei Liu; Zhe-Hui Wang; Qing-San Zhu
Journal:  Eur Spine J       Date:  2015-09-28       Impact factor: 3.134

Review 4.  The great mimicker: IgG4-related disease.

Authors:  Rodolfo Perez Alamino; Luis R Espinoza; Arnold H Zea
Journal:  Clin Rheumatol       Date:  2013-07-23       Impact factor: 2.980

Review 5.  Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Yasuhisa Shinomura
Journal:  Nat Rev Rheumatol       Date:  2013-12-03       Impact factor: 20.543

Review 6.  Idiopathic hypertrophic spinal pachymeningitis: a case report and review of literature.

Authors:  Li-xia Qin; Chun-yu Wang; Zhi-ping Hu; Liu-wang Zeng; Li-ming Tan; Hai-nan Zhang
Journal:  Eur Spine J       Date:  2015-04-24       Impact factor: 3.134

7.  Immunoglobulin g4-related hypertrophic pachymeningitis with skull involvement.

Authors:  Young-Sub Lee; Hye Won Lee; Ki-Su Park; Seong-Hyun Park; Jeong-Hyun Hwang
Journal:  Brain Tumor Res Treat       Date:  2014-10-31

8.  Paraplegia in a Patient With IgG4-Related Sclerosing Disease: A Case Report.

Authors:  Sung Heon Kim; Yeon Kang; Sung Han Oh; Soya Paik; Joo Sup Kim
Journal:  Ann Rehabil Med       Date:  2014-12-24

9.  Freiburg neuropathology case conference: a partially calcified, dura-based tumour of the frontal lobe.

Authors:  C A Taschner; O Staszewski; R Jabbarli; A Keuler; M Prinz
Journal:  Clin Neuroradiol       Date:  2013-01-11       Impact factor: 3.649

10.  Cranial neuropathy because of IgG4-related pachymeningitis; intracranial and spinal mass lesions.

Authors:  Yasutaka Tajima; Yasunori Mito
Journal:  BMJ Case Rep       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.